Susquehanna International Group, LLP Novartis Ag Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $20.9 Million - $23.8 Million	-197,000 Reduced 41.17%	281,500 $32.4 Million
Q2 2024 Aug 15, 2024	BUY	$92.57 - $107.37 $21.1 Million - $24.4 Million	227,500 Added 90.64%	478,500 $50.9 Million
Q1 2024 May 07, 2024	SELL	$95.27 - $108.47 $5.56 Million - $6.33 Million	-58,400 Reduced 18.88%	251,000 $24.3 Million
Q4 2023 Feb 14, 2024	SELL	$92.27 - $101.54 $4.42 Million - $4.86 Million	-47,900 Reduced 13.41%	309,400 $31.2 Million
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $10.2 Million - $11.3 Million	-107,400 Reduced 23.11%	357,300 $36.4 Million
Q2 2023 Aug 11, 2023	BUY	$92.52 - $104.91 $2.84 Million - $3.22 Million	30,700 Added 7.07%	464,700 $46.9 Million
Q1 2023 May 16, 2023	SELL	$80.03 - $92.81 $33.9 Million - $39.3 Million	-423,400 Reduced 49.38%	434,000 $39.9 Million
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $12.7 Million - $15.6 Million	168,300 Added 24.42%	857,400 $77.8 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $5.74 Million - $6.71 Million	-76,900 Reduced 10.04%	689,100 $52.4 Million
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $27.4 Million - $32 Million	-340,800 Reduced 30.79%	766,000 $64.8 Million
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $2.66 Million - $3.01 Million	-33,200 Reduced 2.91%	1,106,800 $97.1 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $23.8 Million - $26.4 Million	299,000 Added 35.55%	1,140,000 $99.7 Million
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $8.6 Million - $10 Million	105,200 Added 14.3%	841,000 $68.8 Million
Q2 2021 Aug 11, 2021	SELL	$85.24 - $94.15 $1.85 Million - $2.04 Million	-21,700 Reduced 2.86%	735,800 $67.1 Million
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $17.8 Million - $20.9 Million	-212,700 Reduced 21.92%	757,500 $64.8 Million
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $12.7 Million - $15.3 Million	162,300 Added 20.09%	970,200 $91.6 Million
Q3 2020 Nov 16, 2020	BUY	$82.14 - $91.0 $6.74 Million - $7.47 Million	82,100 Added 11.31%	807,900 $70.3 Million
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $9.57 Million - $10.8 Million	118,300 Added 19.47%	725,800 $63.4 Million
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $3.1 Million - $4.34 Million	43,800 Added 7.77%	607,500 $50.1 Million
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $6.17 Million - $6.97 Million	73,100 Added 14.9%	563,700 $53.4 Million
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $17.2 Million - $19 Million	-201,600 Reduced 29.12%	490,600 $42.6 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $9.3 Million - $11.5 Million	123,400 Added 21.69%	692,200 $63.2 Million
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $7.06 Million - $8.07 Million	93,700 Added 19.72%	568,800 $54.7 Million
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $13 Million - $14.5 Million	176,300 Added 59.0%	475,100 $40.8 Million
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $6.31 Million - $7.3 Million	-94,300 Reduced 23.99%	298,800 $25.7 Million
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $10.1 Million - $11.4 Million	-154,900 Reduced 28.27%	393,100 $29.7 Million
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $21.5 Million - $25.7 Million	304,900 Added 125.42%	548,000 $44.3 Million
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $11.1 Million - $12 Million	154,000 Added 172.84%	243,100 $20.4 Million
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $6.61 Million - $6.88 Million	89,100	89,100 $7.65 Million

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account